BSW Wealth Partners Boosts Stake in CME Group Inc. (NASDAQ:CME)

BSW Wealth Partners lifted its stake in shares of CME Group Inc. (NASDAQ:CME) by 22.3% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,912 shares of the financial services provider’s stock after acquiring an additional 348 shares during the quarter. BSW Wealth Partners’ holdings in CME Group were worth $422,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Coronation Fund Managers Ltd. increased its position in shares of CME Group by 14.1% in the 3rd quarter. Coronation Fund Managers Ltd. now owns 1,817 shares of the financial services provider’s stock valued at $401,000 after acquiring an additional 224 shares during the period. Harbor Capital Advisors Inc. raised its position in CME Group by 0.6% during the third quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider’s stock valued at $1,723,000 after acquiring an additional 45 shares in the last quarter. Janney Capital Management LLC boosted its stake in shares of CME Group by 3.2% during the 3rd quarter. Janney Capital Management LLC now owns 12,017 shares of the financial services provider’s stock worth $2,652,000 after acquiring an additional 369 shares in the last quarter. Clear Creek Financial Management LLC grew its holdings in CME Group by 4.7% in the third quarter. Clear Creek Financial Management LLC now owns 2,378 shares of the financial services provider’s stock valued at $525,000 after purchasing an additional 107 shares during the period. Finally, First Interstate Bank purchased a new stake in CME Group in the 3rd quarter worth $208,000. 87.75% of the stock is owned by institutional investors.

Insider Transactions at CME Group

In related news, insider Timothy Francis Mccourt sold 1,374 shares of the company’s stock in a transaction dated Monday, October 28th. The shares were sold at an average price of $227.12, for a total value of $312,062.88. Following the sale, the insider now owns 7,275 shares of the company’s stock, valued at $1,652,298. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, insider Timothy Francis Mccourt sold 1,374 shares of the firm’s stock in a transaction that occurred on Monday, October 28th. The shares were sold at an average price of $227.12, for a total value of $312,062.88. Following the completion of the sale, the insider now owns 7,275 shares of the company’s stock, valued at $1,652,298. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the transaction, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,221 shares of company stock worth $3,351,895. 0.30% of the stock is currently owned by company insiders.

CME Group Price Performance

NASDAQ:CME opened at $223.61 on Monday. The business’s 50-day moving average price is $220.69 and its 200 day moving average price is $209.49. The firm has a market cap of $80.52 billion, a P/E ratio of 23.51, a PEG ratio of 5.67 and a beta of 0.55. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $230.36.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter last year, the firm posted $2.25 earnings per share. CME Group’s revenue was up 18.4% compared to the same quarter last year. As a group, sell-side analysts predict that CME Group Inc. will post 10.23 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were issued a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a yield of 2.06%. The ex-dividend date was Monday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 48.37%.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. Oppenheimer lifted their target price on shares of CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a research note on Thursday, October 24th. Royal Bank of Canada restated a “sector perform” rating and issued a $235.00 target price on shares of CME Group in a research report on Thursday, October 24th. Citigroup lifted their target price on shares of CME Group from $250.00 to $255.00 and gave the company a “buy” rating in a report on Thursday, October 24th. TD Cowen began coverage on CME Group in a research report on Thursday, September 26th. They issued a “hold” rating and a $221.00 target price for the company. Finally, Bank of America upped their price objective on CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a research report on Thursday, October 3rd. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $222.73.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.